GCNT4 and neurodegenerative disease: Based on the evidence from the Open Target Platform [37], GCNT4 and MAST2 are related to neurodegenerative disease and measurements of erythrocyte count, BMI, LDL and TC [55–59]; whereas CRTAC1 is related to body fat percentage and measurements of HDL and TG [59, 60].